Animal Genetics Market by Live Animal (Bovine, Porcine, Canine), Products & Services (Genetic Materials (Semen, Embryo), Genetic Testing Services (Disease Tests, Trait Tests), Technology (PCR, NGS, rDNA), End User (Animal Farm) - Global Forecast to 2031
The global animal genetics market was valued at USD 6.64 billion in 2026 and is projected to reach USD 9.37 billion by 2031, growing at a CAGR of 7.1% during the forecast period. This is driven by rising demand for high-quality animal protein and dairy products, increasing focus on livestock productivity, and growing adoption of genomic selection, SNP genotyping, and molecular breeding technologies. These solutions enable faster identification of superior traits such as improved yield, fertility, feed efficiency, and disease resistance. Growing concerns around animal health, antimicrobial resistance, and sustainable livestock production are further accelerating the adoption of genetic improvement programs. Additionally, advancements in AI-based phenotyping, precision livestock farming, sexed semen, and embryo technologies are enhancing breeding accuracy and accelerating genetic gains, while government initiatives to improve livestock productivity in emerging markets are supporting market expansion.
“Bovine embryos are expected to register the highest growth in the embryo market.”
The bovine embryos segment is projected to grow at the highest CAGR between 2026 and 2031 with wider implementation of embryo transfer and in vitro fertilization (IVF) techniques across cattle breeding programs. These technologies enable rapid multiplication and distribution of elite genetics from high-performing animals with desirable traits such as enhanced milk yield, improved growth characteristics, better fertility, feed efficiency, and disease resistance. The integration of genomic testing and embryo screening is improving selection precision by identifying embryos with superior genetic potential at an early stage. Expansion of commercial embryo production facilities, veterinary reproductive service providers, and specialized breeding networks is increasing accessibility to bovine embryo technologies. Additionally, standardized embryo evaluation practices and growing cross-border trade of high-value bovine embryos are strengthening genetic improvement initiatives worldwide.
“By end user, animal farms accounted for the largest share of the animal genetics market in 2025.”
Animal farms held the largest share of the end-user market in 2025, owing to their central role in the adoption of animal genetics solutions across livestock production systems. Farms are the primary users of genetic materials, including semen and embryos, as well as genetic testing and breeding services to improve productivity, animal health, and breeding efficiency. As genomic data and performance-based selection increasingly influence breeding decisions, farms continue to remain key contributors to demand for genetic improvement solutions across poultry, swine, and dairy operations. This segment is expected to maintain its leading position through 2031, supported by continued adoption of advanced breeding technologies and increasing focus on optimizing livestock performance.
Breakdown of Primaries
The study contains insights from various industry experts. The breakdown of the primaries is as follows:
Research Coverage
This research report categorizes the animal genetics market by live animal (poultry, porcine, bovine, canine, and other live animals), by product & service (animal genetic materials and animal genetic testing services), by technology (NGS, PCR, rDNA, microarrays, and other technologies), by end user (animal farms, veterinary hospitals & clinics, diagnostic centers, and research institutes), and by region.
Further type-level segmentation is available in the full report.
The study also includes an in-depth competitive analysis of the market's key players, their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report
The report will provide market leaders and new entrants with the closest approximations of revenue for the overall animal genetics market and its subsegments. It will help stakeholders understand the competitive landscape, gain insights to position their businesses more effectively, and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
“Bovine embryos are expected to register the highest growth in the embryo market.”
The bovine embryos segment is projected to grow at the highest CAGR between 2026 and 2031 with wider implementation of embryo transfer and in vitro fertilization (IVF) techniques across cattle breeding programs. These technologies enable rapid multiplication and distribution of elite genetics from high-performing animals with desirable traits such as enhanced milk yield, improved growth characteristics, better fertility, feed efficiency, and disease resistance. The integration of genomic testing and embryo screening is improving selection precision by identifying embryos with superior genetic potential at an early stage. Expansion of commercial embryo production facilities, veterinary reproductive service providers, and specialized breeding networks is increasing accessibility to bovine embryo technologies. Additionally, standardized embryo evaluation practices and growing cross-border trade of high-value bovine embryos are strengthening genetic improvement initiatives worldwide.
“By end user, animal farms accounted for the largest share of the animal genetics market in 2025.”
Animal farms held the largest share of the end-user market in 2025, owing to their central role in the adoption of animal genetics solutions across livestock production systems. Farms are the primary users of genetic materials, including semen and embryos, as well as genetic testing and breeding services to improve productivity, animal health, and breeding efficiency. As genomic data and performance-based selection increasingly influence breeding decisions, farms continue to remain key contributors to demand for genetic improvement solutions across poultry, swine, and dairy operations. This segment is expected to maintain its leading position through 2031, supported by continued adoption of advanced breeding technologies and increasing focus on optimizing livestock performance.
Breakdown of Primaries
The study contains insights from various industry experts. The breakdown of the primaries is as follows:
- By Company Type: Tier 1 – 35%, Tier 2 – 40%, and Tier 3 – 25%
- By Designation: C-Level – 35%, Director Level – 25%, and Others – 40%
- By Region: North America – 40%, Europe – 25%, Asia Pacific – 20%, Middle East & Africa – 8%, Latin America – 7%
Research Coverage
This research report categorizes the animal genetics market by live animal (poultry, porcine, bovine, canine, and other live animals), by product & service (animal genetic materials and animal genetic testing services), by technology (NGS, PCR, rDNA, microarrays, and other technologies), by end user (animal farms, veterinary hospitals & clinics, diagnostic centers, and research institutes), and by region.
Further type-level segmentation is available in the full report.
The study also includes an in-depth competitive analysis of the market's key players, their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report
The report will provide market leaders and new entrants with the closest approximations of revenue for the overall animal genetics market and its subsegments. It will help stakeholders understand the competitive landscape, gain insights to position their businesses more effectively, and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (increasing consumption of high-quality animal-derived protein and dairy products, rising focus on improving animal health, livestock productivity, and breeding efficiency through animal genetics, prevention of genetic diseases through advanced genetic services, growing adoption of molecular and genomic tools in livestock improvement programs), restraints (high cost associated with advanced genetic testing, limiting adoption of animal genetic services, technical limitations in accuracy and interpretation of genetic testing technologies), opportunities (untapped market potential in developing countries, integration of advanced phenotyping technologies with genomic selection programs, rising investments in animal genetics research and product innovation), and challenges (developing breed-specific genetic improvement programs for locally adapted animal populations, lack of technical expertise among animal genetics professionals)
- Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and new product and service launches in the animal genetics market.
- Market Development: Comprehensive information about lucrative markets—the report analyzes the animal genetics market across varied regions.
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the animal genetics market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Hendrix Genetics BV (Netherlands), Topigs Norsvin (Netherlands), Genus plc (UK), URUS Group LP (US), and CRV (Netherlands)
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGE
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN ANIMAL GENETICS MARKET
2.4 HIGH GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 ANIMAL GENETICS MARKET OVERVIEW
3.2 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY AND END USER
3.3 GEOGRAPHIC SNAPSHOT OF ANIMAL GENETICS MARKET
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing consumption of high-quality animal-derived protein and dairy products
4.2.1.2 Rising focus on improving animal health, livestock productivity and breeding efficiency through animal genetics
4.2.1.3 Prevention of genetic diseases through advanced genetic services
4.2.1.4 Growing adoption of molecular and genomic tools in livestock improvements
4.2.2 RESTRAINTS
4.2.2.1 High cost associated with advanced genetic testing limiting adoption of animal genetic services
4.2.2.2 Technical limitations in accuracy and interpretation of genetic testing technologies
4.2.3 OPPORTUNITIES
4.2.3.1 Untapped market potential in developing countries
4.2.3.2 Integration of advanced phenotyping technologies with genomic selection programs
4.2.3.3 Rising investments in animal genetics research and product innovation
4.2.4 CHALLENGES
4.2.4.1 Developing breed-specific genetic improvement programs for locally adapted animal populations
4.2.4.2 Lack of technical expertise among animal genetics professionals
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN ANIMAL GENETICS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL ANIMAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT & SERVICE MARKET (2023–2025)
5.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY MARKET
5.6.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER
5.6.4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
5.7 TRADE ANALYSIS
5.7.1 TRADE DATA FOR HS CODE 051110
5.7.1.1 Import data for HS Code 051110
5.7.1.2 Export data for HS Code 051110
5.8 KEY CONFERENCES & EVENTS
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.12 IMPACT OF 2025 US TARIFFS – ANIMAL GENETICS MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUTRY/REGION
5.12.5 IMPACT ON END-USE INDUSTRIES
5.12.5.1 Animal farms
5.12.5.2 Veterinary hospitals and clinics
5.12.5.3 Diagnostics center
5.12.5.4 Research center
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 CRISPR-CAS9 GENE EDITING
6.1.2 PRECISION PHENOTYPING
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 ARTIFICIAL INSEMINATION
6.2.2 EMBRYO TRANSFER TECHNOLOGY
6.3 ADJACENT TECHNOLOGIES
6.3.1 ARTIFICIAL INTELLIGENCE (AI)
6.3.2 PRECISION LIVESTOCK FARMING
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 NEAR TERM (2025–2027)
6.4.2 MID-TERM (2028–2030)
6.4.3 LONG TERM (2030+)
6.5 PATENT ANALYSIS
6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 PRECISION BREEDING AND GENOMIC SELECTION
6.6.2 DEVELOPMENT OF DISEASE-RESISTANT AND HEALTHIER ANIMAL BREEDS
6.6.3 CLIMATE-RESILIENT LIVESTOCK PRODUCTION
6.6.4 CONSERVATION AND RESTORATION OF VALUABLE ANIMAL GENETIC RESOURCES
6.6.5 PERSONALIZED BREEDING PROGRAMS USING AI AND GENOMIC DATA ANALYTICS
6.7 IMPACT OF AI/GENERATIVE AI ON ANIMAL GENETICS MARKET
6.7.1 TOP USE CASES AND MARKET POTENTIAL
6.7.2 BEST PRACTICES IN ANIMAL GENETICS MARKET
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS – ANIMAL GENETICS MARKET
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ANIMAL GENETICS
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.1.1 North America
7.1.1.2 Europe
7.1.1.3 APAC
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2 INDUSTRY STANDARDS
7.2.1 TESTING LABORATORY COMPETENCE STANDARD – ISO/IEC 17025:2017
7.2.2 QUALITY MANAGEMENT SYSTEM STANDARD – ISO 9001:2015
7.2.3 BIOBANKING OF ANIMAL GERMPLASM STANDARD – ISO 16677-1:2025
7.2.4 BIOTECHNOLOGY — BIOPROCESSING STANDARD – ISO 20688-1:2024
7.2.5 INFORMATION SECURITY MANAGEMENT STANDARD – ISO/IEC 27001:2022
7.3 SUSTAINABILITY INITIATIVES
7.3.1 SUSTAINABLE ANIMAL HEALTH AND GENETICS INNOVATION - ZOETIS SERVICES LLC.
7.3.2 ADVANCING SUSTAINABILITY THROUGH ANIMAL GENETICS – GENUS PLC
7.3.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS & BUYING CRITERIA
8.2.1 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 ANIMAL GENETICS MARKET, BY LIVE ANIMAL
9.1 INTRODUCTION
9.2 BOVINE
9.2.1 INCREASING FOCUS ON MAXIMIZING PRODUCTION EFFICIENCY TO DRIVE MARKET
9.3 PORCINE
9.3.1 INCREASING APPLICATION OF ADVANCED GENETIC TECHNIQUES TO AID MARKET GROWTH
9.4 CANINE
9.4.1 RISING AWARENESS OF GENETIC HEALTH IN DOGS TO SUPPORT GROWTH
9.5 POULTRY
9.5.1 RISING DEMAND FOR CHICKEN AND EGG AS PRIMARY PROTEIN SOURCES TO DRIVE MARKET
9.6 OTHER LIVE ANIMALS
10 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE
10.1 INTRODUCTION
10.2 ANIMAL GENETIC MATERIALS
10.2.1 SEMEN
10.2.1.1 Bovine semen
10.2.1.1.1 Bovine semen to register highest growth rate during study period
10.2.1.2 Porcine semen
10.2.1.2.1 Rising use of artificial insemination to propel market growth
10.2.1.3 Equine semen
10.2.1.3.1 Stringent regulations for disease control to pose challenges for equine industry breeders
10.2.1.4 Canine semen
10.2.1.4.1 Increasing adoption of dogs as companion animals to drive market
10.2.1.5 Other animal semen
10.2.2 EMBRYOS
10.2.2.1 Bovine embryos
10.2.2.1.1 Growing popularity among seed stock and beef producers to support market growth
10.2.2.2 Equine embryos
10.2.2.2.1 Argentina, Brazil, and US to hold leading shares in embryo transfer technology
10.2.2.3 Other animal embryos
10.3 ANIMAL GENETIC TESTING SERVICES
10.3.1 GENETIC DISEASE TESTS
10.3.1.1 Genetic disease tests to witness highest growth in testing services market
10.3.2 GENETIC TRAIT TESTS
10.3.2.1 Bovine genetic trait tests
10.3.2.1.1 Focus on high-productivity traits in herds to drive demand
10.3.2.2 Other genetic trait tests
10.3.3 DNA TYPING
10.3.3.1 Emphasis on parentage identification, animal registration, and gender-associated disease identification to propel market
10.3.4 OTHER SERVICES
11 ANIMAL GENETICS MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 NGS (NEXT-GENERATION SEQUENCING)
11.2.1 INCREASING APPLICATIONS IN AND RISING GLOBAL DEMAND FOR CHICKEN AND EGGS TO SUPPORT GROWTH
11.3 PCR (POLYMERASE CHAIN REACTION)
11.3.1 COST-EFFECTIVENESS, SIMPLICITY, AND HIGH ACCURACY TO DRIVE MARKET
11.4 RDNA (RECOMBINANT DNA TECHNOLOGY)
11.4.1 ABILITY TO SUPPORT GENETIC ENGINEERING AND GMOS TO SUPPORT MARKET GROWTH
11.5 MICROARRAYS
11.5.1 RAPID ANALYTICAL CAPABILITIES TO PROPEL ADOPTION OF MICROARRAYS
11.6 OTHER TECHNOLOGIES
12 ANIMAL GENETICS MARKET, BY END USER
12.1 INTRODUCTION
12.2 ANIMAL FARMS
12.2.1 GROWING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
12.3 VETERINARY HOSPITALS & CLINICS
12.3.1 RISING INVESTMENTS AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL GROWTHS
12.4 DAIGNOSTIC CENTERS
12.4.1 RISING DEMAND FOR ACCURATE AND TIMELY DIAGNOSIS TO SUPPORT MARKET GROWTH
12.5 RESEARCH INSTITUTES
12.5.1 INCREASED FUNDING FOR RESEARCH AND GOVERNMENT INITIATIVES TO DRIVE MARKET
13 ANIMAL GENETICS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2 US
13.2.2.1 Adoption of advanced genetic testing methods to drive growth of market
13.2.3 CANADA
13.2.3.1 Growing demand for genetic material to boost market growth
13.3 EUROPE
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2 GERMANY
13.3.2.1 Growing adoption of genomic breeding and sustainable livestock production drives the animal genetics market
13.3.3 UK
13.3.3.1 Selective breeding programs and efforts to improve breed productivity to drive demand for animal genetics
13.3.4 FRANCE
13.3.4.1 Growing demand for livestock and poultry products drives the animal genetics market
13.3.5 ITALY
13.3.5.1 Government initiatives to conserve indigenous breeds and improve livestock productivity drive market growth
13.3.6 SPAIN
13.3.6.1 Rising demand for pork and poultry products supports the growth of the animal genetics market
13.3.7 NETHERLANDS
13.3.7.1 Strong livestock sector and growing presence of key market players to drive the animal genetics market
13.3.8 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2 CHINA
13.4.2.1 China to hold largest share of animal genetics market
13.4.3 INDIA
13.4.3.1 Large dairy cattle population and increasing demand for superior genetics drive market growth
13.4.4 JAPAN
13.4.4.1 Increased production and consumption of livestock products to drive market growth
13.4.5 AUSTRALIA
13.4.5.1 Increasing demand for animal-derived food products to propel market growth
13.4.6 SOUTH KOREA
13.4.6.1 Growing demand for premium animal protein and advanced breeding technologies drive market growth
13.4.7 REST OF ASIA PACIFIC
13.5 LATIN AMERICA
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2 BRAZIL
13.5.2.1 Brazil to hold largest share of LATAM market
13.5.3 MEXICO
13.5.3.1 High demand for animal meat to drive market growth in Mexico
13.5.4 REST OF LATIN AMERICA
13.6 MIDDLE EAST & AFRICA
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
13.6.2 GCC COUNTRIES
13.6.2.1 Emphasis on improving animal welfare standards to support market demand
13.6.2.2 Kingdom of Saudi Arabia
13.6.2.2.1 Kingdom of Saudi Arabia to hold the largest share of the Middle East Animal genetics market
13.6.2.3 United Arab Emirates
13.6.2.3.1 Growing adoption of animal genetics technologies in UAE
13.6.2.4 Rest of GCC Countries
13.6.3 REST OF MIDDLE EAST AND AFRICA
14 COMPETITIVE LANDSCAPE
14.1 INTRODUCTION
14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024–2026
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL GENETICS MARKET
14.3 REVENUE ANALYSIS, 2023–2025
14.3.1 ANIMAL GENETICS MARKET: REVENUE ANALYSIS
14.4 MARKET SHARE ANALYSIS, 2025
14.4.1 GLOBAL SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.4.2 US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.4.3 EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.5.1 STARS
14.5.2 EMERGING LEADERS
14.5.3 PERVASIVE PLAYERS
14.5.4 PARTICIPANTS
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
14.5.5.1 Company footprint
14.5.5.2 Region footprint
14.5.5.3 Live animals footprint
14.5.5.4 Product and services footprint
14.5.5.5 Technology footprint
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.6.1 PROGRESSIVE COMPANIES
14.6.2 RESPONSIVE COMPANIES
14.6.3 DYNAMIC COMPANIES
14.6.4 STARTING BLOCKS
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES
14.6.5.1 Detailed list of key startups/SMEs
14.6.5.2 Competitive benchmarking of key startups/SMEs
14.7 COMPANY VALUATION AND FINANCIAL METRICS
14.7.1 FINANCIAL METRICS
14.7.2 COMPANY VALUATION
14.8 BRAND/PRODUCT COMPARISON
14.9 COMPETITIVE SCENARIO
14.9.1 PRODUCT LAUNCHES & APPROVALS
14.9.2 DEALS
14.9.3 EXPANSIONS
14.9.4 OTHER DEVELOPMENTS
15 COMPANY PROFILES
15.1 KEY PLAYERS
15.1.1 GENUS PLC
15.1.1.1 Business overview
15.1.1.2 Products/Service offered
15.1.1.3 Recent developments
15.1.1.3.1 Product/Service launches & approvals
15.1.1.3.2 Deals
15.1.1.3.3 Other developments
15.1.1.4 MnM view
15.1.1.4.1 Right to win
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses and competitive threats
15.1.2 NEOGEN CORPORATION
15.1.2.1 Business overview
15.1.2.2 Products /Services offered
15.1.2.3 Recent developments
15.1.2.3.1 Product/Service launches and approvals
15.1.2.3.2 Deals
15.1.2.3.3 Expansions
15.1.2.4 MnM view
15.1.2.4.1 Right to win
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses and competitive threats
15.1.3 EUROFINS SCIENTIFIC
15.1.3.1 Business overview
15.1.3.2 Products/Services offered
15.1.3.3 Recent developments
15.1.3.3.1 Deals
15.1.3.4 MnM view
15.1.3.4.1 Right to win
15.1.3.4.2 Strategic choices
15.1.3.4.3 Weaknesses and competitive threats
15.1.4 THERMO FISHER SCIENTIFIC INC
15.1.4.1 Business overview
15.1.4.2 Products/Services offered
15.1.4.3 Recent developments
15.1.4.3.1 Product/Services launches and approvals
15.1.4.4 MnM view
15.1.4.4.1 Right to win
15.1.4.4.2 Strategic choices
15.1.4.4.3 Weaknesses and competitive threats
15.1.5 ZOETIS SERVICES LLC
15.1.5.1 Business overview
15.1.5.2 Products/Services offered
15.1.5.3 Recent developments
15.1.5.3.1 Product & Service launches
15.1.5.3.2 Deals
15.1.5.3.3 Other developments
15.1.6 ILLUMINA, INC.
15.1.6.1 Business overview
15.1.6.2 Products/Services offered
15.1.7 HENDRIX GENETICS BV
15.1.7.1 Business overview
15.1.7.2 Products/Services offered
15.1.7.3 Recent developments
15.1.7.3.1 Product & Service launches
15.1.7.3.2 Deals
15.1.7.3.3 Expansions
15.1.7.3.4 Other developments
15.1.8 CRV
15.1.8.1 Business overview
15.1.8.2 Products/Services offered
15.1.8.3 Recent developments
15.1.8.3.1 Product/Services launches and approvals
15.1.8.3.2 Deals
15.1.9 TOPIGS NORSVIN EN
15.1.9.1 Business overview
15.1.9.2 Products/Services offered
15.1.9.3 Recent developments
15.1.9.3.1 Product/Service launches & approvals
15.1.9.3.2 Deals
15.1.9.3.3 Expansions
15.1.9.3.4 Other developments
15.1.10 URUS GROUP LP
15.1.10.1 Business overview
15.1.10.2 Products/Services offered
15.1.10.3 Recent developments
15.1.10.3.1 Product/Services launches and approvals
15.1.10.3.2 Deals
15.1.10.3.3 Expansions
15.1.10.4 MnM view
15.1.10.4.1 Right to win
15.1.10.4.2 Strategic choices
15.1.10.4.3 Weaknesses and competitive threats
15.1.11 SELECT SIRES INC.
15.1.11.1 Business overview
15.1.11.2 Products/Services offered
15.1.11.3 Recent developments
15.1.11.3.1 Product/Services launches and approvals
15.1.11.3.2 Deals
15.1.12 GROUPE GRIMAUD
15.1.12.1 Business overview
15.1.12.2 Products/Services offered
15.1.12.3 Recent developments
15.1.12.3.1 Expansions
15.1.12.3.2 Other developments
15.1.13 QUANTUM GENETIX/BIOSCIENCES
15.1.13.1 Business overview
15.1.13.2 Products/Services offered
15.1.13.3 Recent developments
15.1.13.3.1 Other developments
15.1.14 ANIMAL GENETICS, INC.
15.1.14.1 Business overview
15.1.14.2 Products/Services offered
15.1.15 SEMEX
15.1.15.1 Business overview
15.1.15.2 Products/Services offered
15.1.15.3 Recent developments
15.1.15.3.1 Deals
15.1.15.3.2 Expansions
15.2 OTHER PLAYERS
15.2.1 LABOKLIN GMBH & CO. KG
15.2.2 DANBRED P/S
15.2.3 TROPICAL ANIMAL GENETICS
15.2.4 INGURAN LLC DBA STGENETICS
15.2.5 SUPERIOR ANIMAL GENETICS
15.2.6 XYTOVET
15.2.7 SWINE GENETICS INTERNATIONAL
15.2.8 GENERATIO GMBH
15.2.9 GENSOL DIAGNOSTICS, LLC.
15.2.10 SANDOR ANIMAL BIOGENICS PVT. LTD.
16 RESEARCH METHODOLOGY
16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.2 PRIMARY DATA
16.1.2.1 Breakdown of primary interviews
16.1.2.2 Key industry insights
16.2 MARKET SIZE ESTIMATION
16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
16.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
16.2.4 TOP-DOWN APPROACH
16.2.5 BASE NUMBER CALCULATION
16.2.5.1 Company presentations
16.2.5.2 Primary interviews
16.2.6 VOLUME ESTIMATION
16.2.7 DEMAND-SIDE APPROACH
16.3 MARKET BREAKDOWN AND DATA TRIANGULATION
16.4 MARKET SHARE ASSESSMENT
16.5 RESEARCH ASSUMPTIONS
16.5.1 STUDY ASSUMPTIONS
16.5.2 GROWTH RATE ASSUMPTIONS
16.6 RISK ASSESSMENT
16.6.1 RESEARCH LIMITATIONS
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGE
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN ANIMAL GENETICS MARKET
2.4 HIGH GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 ANIMAL GENETICS MARKET OVERVIEW
3.2 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY AND END USER
3.3 GEOGRAPHIC SNAPSHOT OF ANIMAL GENETICS MARKET
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing consumption of high-quality animal-derived protein and dairy products
4.2.1.2 Rising focus on improving animal health, livestock productivity and breeding efficiency through animal genetics
4.2.1.3 Prevention of genetic diseases through advanced genetic services
4.2.1.4 Growing adoption of molecular and genomic tools in livestock improvements
4.2.2 RESTRAINTS
4.2.2.1 High cost associated with advanced genetic testing limiting adoption of animal genetic services
4.2.2.2 Technical limitations in accuracy and interpretation of genetic testing technologies
4.2.3 OPPORTUNITIES
4.2.3.1 Untapped market potential in developing countries
4.2.3.2 Integration of advanced phenotyping technologies with genomic selection programs
4.2.3.3 Rising investments in animal genetics research and product innovation
4.2.4 CHALLENGES
4.2.4.1 Developing breed-specific genetic improvement programs for locally adapted animal populations
4.2.4.2 Lack of technical expertise among animal genetics professionals
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN ANIMAL GENETICS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL ANIMAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT & SERVICE MARKET (2023–2025)
5.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY MARKET
5.6.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER
5.6.4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
5.7 TRADE ANALYSIS
5.7.1 TRADE DATA FOR HS CODE 051110
5.7.1.1 Import data for HS Code 051110
5.7.1.2 Export data for HS Code 051110
5.8 KEY CONFERENCES & EVENTS
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.12 IMPACT OF 2025 US TARIFFS – ANIMAL GENETICS MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUTRY/REGION
5.12.5 IMPACT ON END-USE INDUSTRIES
5.12.5.1 Animal farms
5.12.5.2 Veterinary hospitals and clinics
5.12.5.3 Diagnostics center
5.12.5.4 Research center
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 CRISPR-CAS9 GENE EDITING
6.1.2 PRECISION PHENOTYPING
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 ARTIFICIAL INSEMINATION
6.2.2 EMBRYO TRANSFER TECHNOLOGY
6.3 ADJACENT TECHNOLOGIES
6.3.1 ARTIFICIAL INTELLIGENCE (AI)
6.3.2 PRECISION LIVESTOCK FARMING
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 NEAR TERM (2025–2027)
6.4.2 MID-TERM (2028–2030)
6.4.3 LONG TERM (2030+)
6.5 PATENT ANALYSIS
6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 PRECISION BREEDING AND GENOMIC SELECTION
6.6.2 DEVELOPMENT OF DISEASE-RESISTANT AND HEALTHIER ANIMAL BREEDS
6.6.3 CLIMATE-RESILIENT LIVESTOCK PRODUCTION
6.6.4 CONSERVATION AND RESTORATION OF VALUABLE ANIMAL GENETIC RESOURCES
6.6.5 PERSONALIZED BREEDING PROGRAMS USING AI AND GENOMIC DATA ANALYTICS
6.7 IMPACT OF AI/GENERATIVE AI ON ANIMAL GENETICS MARKET
6.7.1 TOP USE CASES AND MARKET POTENTIAL
6.7.2 BEST PRACTICES IN ANIMAL GENETICS MARKET
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS – ANIMAL GENETICS MARKET
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ANIMAL GENETICS
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.1.1 North America
7.1.1.2 Europe
7.1.1.3 APAC
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2 INDUSTRY STANDARDS
7.2.1 TESTING LABORATORY COMPETENCE STANDARD – ISO/IEC 17025:2017
7.2.2 QUALITY MANAGEMENT SYSTEM STANDARD – ISO 9001:2015
7.2.3 BIOBANKING OF ANIMAL GERMPLASM STANDARD – ISO 16677-1:2025
7.2.4 BIOTECHNOLOGY — BIOPROCESSING STANDARD – ISO 20688-1:2024
7.2.5 INFORMATION SECURITY MANAGEMENT STANDARD – ISO/IEC 27001:2022
7.3 SUSTAINABILITY INITIATIVES
7.3.1 SUSTAINABLE ANIMAL HEALTH AND GENETICS INNOVATION - ZOETIS SERVICES LLC.
7.3.2 ADVANCING SUSTAINABILITY THROUGH ANIMAL GENETICS – GENUS PLC
7.3.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS & BUYING CRITERIA
8.2.1 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 ANIMAL GENETICS MARKET, BY LIVE ANIMAL
9.1 INTRODUCTION
9.2 BOVINE
9.2.1 INCREASING FOCUS ON MAXIMIZING PRODUCTION EFFICIENCY TO DRIVE MARKET
9.3 PORCINE
9.3.1 INCREASING APPLICATION OF ADVANCED GENETIC TECHNIQUES TO AID MARKET GROWTH
9.4 CANINE
9.4.1 RISING AWARENESS OF GENETIC HEALTH IN DOGS TO SUPPORT GROWTH
9.5 POULTRY
9.5.1 RISING DEMAND FOR CHICKEN AND EGG AS PRIMARY PROTEIN SOURCES TO DRIVE MARKET
9.6 OTHER LIVE ANIMALS
10 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE
10.1 INTRODUCTION
10.2 ANIMAL GENETIC MATERIALS
10.2.1 SEMEN
10.2.1.1 Bovine semen
10.2.1.1.1 Bovine semen to register highest growth rate during study period
10.2.1.2 Porcine semen
10.2.1.2.1 Rising use of artificial insemination to propel market growth
10.2.1.3 Equine semen
10.2.1.3.1 Stringent regulations for disease control to pose challenges for equine industry breeders
10.2.1.4 Canine semen
10.2.1.4.1 Increasing adoption of dogs as companion animals to drive market
10.2.1.5 Other animal semen
10.2.2 EMBRYOS
10.2.2.1 Bovine embryos
10.2.2.1.1 Growing popularity among seed stock and beef producers to support market growth
10.2.2.2 Equine embryos
10.2.2.2.1 Argentina, Brazil, and US to hold leading shares in embryo transfer technology
10.2.2.3 Other animal embryos
10.3 ANIMAL GENETIC TESTING SERVICES
10.3.1 GENETIC DISEASE TESTS
10.3.1.1 Genetic disease tests to witness highest growth in testing services market
10.3.2 GENETIC TRAIT TESTS
10.3.2.1 Bovine genetic trait tests
10.3.2.1.1 Focus on high-productivity traits in herds to drive demand
10.3.2.2 Other genetic trait tests
10.3.3 DNA TYPING
10.3.3.1 Emphasis on parentage identification, animal registration, and gender-associated disease identification to propel market
10.3.4 OTHER SERVICES
11 ANIMAL GENETICS MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 NGS (NEXT-GENERATION SEQUENCING)
11.2.1 INCREASING APPLICATIONS IN AND RISING GLOBAL DEMAND FOR CHICKEN AND EGGS TO SUPPORT GROWTH
11.3 PCR (POLYMERASE CHAIN REACTION)
11.3.1 COST-EFFECTIVENESS, SIMPLICITY, AND HIGH ACCURACY TO DRIVE MARKET
11.4 RDNA (RECOMBINANT DNA TECHNOLOGY)
11.4.1 ABILITY TO SUPPORT GENETIC ENGINEERING AND GMOS TO SUPPORT MARKET GROWTH
11.5 MICROARRAYS
11.5.1 RAPID ANALYTICAL CAPABILITIES TO PROPEL ADOPTION OF MICROARRAYS
11.6 OTHER TECHNOLOGIES
12 ANIMAL GENETICS MARKET, BY END USER
12.1 INTRODUCTION
12.2 ANIMAL FARMS
12.2.1 GROWING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
12.3 VETERINARY HOSPITALS & CLINICS
12.3.1 RISING INVESTMENTS AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL GROWTHS
12.4 DAIGNOSTIC CENTERS
12.4.1 RISING DEMAND FOR ACCURATE AND TIMELY DIAGNOSIS TO SUPPORT MARKET GROWTH
12.5 RESEARCH INSTITUTES
12.5.1 INCREASED FUNDING FOR RESEARCH AND GOVERNMENT INITIATIVES TO DRIVE MARKET
13 ANIMAL GENETICS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2 US
13.2.2.1 Adoption of advanced genetic testing methods to drive growth of market
13.2.3 CANADA
13.2.3.1 Growing demand for genetic material to boost market growth
13.3 EUROPE
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2 GERMANY
13.3.2.1 Growing adoption of genomic breeding and sustainable livestock production drives the animal genetics market
13.3.3 UK
13.3.3.1 Selective breeding programs and efforts to improve breed productivity to drive demand for animal genetics
13.3.4 FRANCE
13.3.4.1 Growing demand for livestock and poultry products drives the animal genetics market
13.3.5 ITALY
13.3.5.1 Government initiatives to conserve indigenous breeds and improve livestock productivity drive market growth
13.3.6 SPAIN
13.3.6.1 Rising demand for pork and poultry products supports the growth of the animal genetics market
13.3.7 NETHERLANDS
13.3.7.1 Strong livestock sector and growing presence of key market players to drive the animal genetics market
13.3.8 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2 CHINA
13.4.2.1 China to hold largest share of animal genetics market
13.4.3 INDIA
13.4.3.1 Large dairy cattle population and increasing demand for superior genetics drive market growth
13.4.4 JAPAN
13.4.4.1 Increased production and consumption of livestock products to drive market growth
13.4.5 AUSTRALIA
13.4.5.1 Increasing demand for animal-derived food products to propel market growth
13.4.6 SOUTH KOREA
13.4.6.1 Growing demand for premium animal protein and advanced breeding technologies drive market growth
13.4.7 REST OF ASIA PACIFIC
13.5 LATIN AMERICA
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2 BRAZIL
13.5.2.1 Brazil to hold largest share of LATAM market
13.5.3 MEXICO
13.5.3.1 High demand for animal meat to drive market growth in Mexico
13.5.4 REST OF LATIN AMERICA
13.6 MIDDLE EAST & AFRICA
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
13.6.2 GCC COUNTRIES
13.6.2.1 Emphasis on improving animal welfare standards to support market demand
13.6.2.2 Kingdom of Saudi Arabia
13.6.2.2.1 Kingdom of Saudi Arabia to hold the largest share of the Middle East Animal genetics market
13.6.2.3 United Arab Emirates
13.6.2.3.1 Growing adoption of animal genetics technologies in UAE
13.6.2.4 Rest of GCC Countries
13.6.3 REST OF MIDDLE EAST AND AFRICA
14 COMPETITIVE LANDSCAPE
14.1 INTRODUCTION
14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024–2026
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL GENETICS MARKET
14.3 REVENUE ANALYSIS, 2023–2025
14.3.1 ANIMAL GENETICS MARKET: REVENUE ANALYSIS
14.4 MARKET SHARE ANALYSIS, 2025
14.4.1 GLOBAL SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.4.2 US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.4.3 EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.5.1 STARS
14.5.2 EMERGING LEADERS
14.5.3 PERVASIVE PLAYERS
14.5.4 PARTICIPANTS
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
14.5.5.1 Company footprint
14.5.5.2 Region footprint
14.5.5.3 Live animals footprint
14.5.5.4 Product and services footprint
14.5.5.5 Technology footprint
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.6.1 PROGRESSIVE COMPANIES
14.6.2 RESPONSIVE COMPANIES
14.6.3 DYNAMIC COMPANIES
14.6.4 STARTING BLOCKS
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES
14.6.5.1 Detailed list of key startups/SMEs
14.6.5.2 Competitive benchmarking of key startups/SMEs
14.7 COMPANY VALUATION AND FINANCIAL METRICS
14.7.1 FINANCIAL METRICS
14.7.2 COMPANY VALUATION
14.8 BRAND/PRODUCT COMPARISON
14.9 COMPETITIVE SCENARIO
14.9.1 PRODUCT LAUNCHES & APPROVALS
14.9.2 DEALS
14.9.3 EXPANSIONS
14.9.4 OTHER DEVELOPMENTS
15 COMPANY PROFILES
15.1 KEY PLAYERS
15.1.1 GENUS PLC
15.1.1.1 Business overview
15.1.1.2 Products/Service offered
15.1.1.3 Recent developments
15.1.1.3.1 Product/Service launches & approvals
15.1.1.3.2 Deals
15.1.1.3.3 Other developments
15.1.1.4 MnM view
15.1.1.4.1 Right to win
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses and competitive threats
15.1.2 NEOGEN CORPORATION
15.1.2.1 Business overview
15.1.2.2 Products /Services offered
15.1.2.3 Recent developments
15.1.2.3.1 Product/Service launches and approvals
15.1.2.3.2 Deals
15.1.2.3.3 Expansions
15.1.2.4 MnM view
15.1.2.4.1 Right to win
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses and competitive threats
15.1.3 EUROFINS SCIENTIFIC
15.1.3.1 Business overview
15.1.3.2 Products/Services offered
15.1.3.3 Recent developments
15.1.3.3.1 Deals
15.1.3.4 MnM view
15.1.3.4.1 Right to win
15.1.3.4.2 Strategic choices
15.1.3.4.3 Weaknesses and competitive threats
15.1.4 THERMO FISHER SCIENTIFIC INC
15.1.4.1 Business overview
15.1.4.2 Products/Services offered
15.1.4.3 Recent developments
15.1.4.3.1 Product/Services launches and approvals
15.1.4.4 MnM view
15.1.4.4.1 Right to win
15.1.4.4.2 Strategic choices
15.1.4.4.3 Weaknesses and competitive threats
15.1.5 ZOETIS SERVICES LLC
15.1.5.1 Business overview
15.1.5.2 Products/Services offered
15.1.5.3 Recent developments
15.1.5.3.1 Product & Service launches
15.1.5.3.2 Deals
15.1.5.3.3 Other developments
15.1.6 ILLUMINA, INC.
15.1.6.1 Business overview
15.1.6.2 Products/Services offered
15.1.7 HENDRIX GENETICS BV
15.1.7.1 Business overview
15.1.7.2 Products/Services offered
15.1.7.3 Recent developments
15.1.7.3.1 Product & Service launches
15.1.7.3.2 Deals
15.1.7.3.3 Expansions
15.1.7.3.4 Other developments
15.1.8 CRV
15.1.8.1 Business overview
15.1.8.2 Products/Services offered
15.1.8.3 Recent developments
15.1.8.3.1 Product/Services launches and approvals
15.1.8.3.2 Deals
15.1.9 TOPIGS NORSVIN EN
15.1.9.1 Business overview
15.1.9.2 Products/Services offered
15.1.9.3 Recent developments
15.1.9.3.1 Product/Service launches & approvals
15.1.9.3.2 Deals
15.1.9.3.3 Expansions
15.1.9.3.4 Other developments
15.1.10 URUS GROUP LP
15.1.10.1 Business overview
15.1.10.2 Products/Services offered
15.1.10.3 Recent developments
15.1.10.3.1 Product/Services launches and approvals
15.1.10.3.2 Deals
15.1.10.3.3 Expansions
15.1.10.4 MnM view
15.1.10.4.1 Right to win
15.1.10.4.2 Strategic choices
15.1.10.4.3 Weaknesses and competitive threats
15.1.11 SELECT SIRES INC.
15.1.11.1 Business overview
15.1.11.2 Products/Services offered
15.1.11.3 Recent developments
15.1.11.3.1 Product/Services launches and approvals
15.1.11.3.2 Deals
15.1.12 GROUPE GRIMAUD
15.1.12.1 Business overview
15.1.12.2 Products/Services offered
15.1.12.3 Recent developments
15.1.12.3.1 Expansions
15.1.12.3.2 Other developments
15.1.13 QUANTUM GENETIX/BIOSCIENCES
15.1.13.1 Business overview
15.1.13.2 Products/Services offered
15.1.13.3 Recent developments
15.1.13.3.1 Other developments
15.1.14 ANIMAL GENETICS, INC.
15.1.14.1 Business overview
15.1.14.2 Products/Services offered
15.1.15 SEMEX
15.1.15.1 Business overview
15.1.15.2 Products/Services offered
15.1.15.3 Recent developments
15.1.15.3.1 Deals
15.1.15.3.2 Expansions
15.2 OTHER PLAYERS
15.2.1 LABOKLIN GMBH & CO. KG
15.2.2 DANBRED P/S
15.2.3 TROPICAL ANIMAL GENETICS
15.2.4 INGURAN LLC DBA STGENETICS
15.2.5 SUPERIOR ANIMAL GENETICS
15.2.6 XYTOVET
15.2.7 SWINE GENETICS INTERNATIONAL
15.2.8 GENERATIO GMBH
15.2.9 GENSOL DIAGNOSTICS, LLC.
15.2.10 SANDOR ANIMAL BIOGENICS PVT. LTD.
16 RESEARCH METHODOLOGY
16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.2 PRIMARY DATA
16.1.2.1 Breakdown of primary interviews
16.1.2.2 Key industry insights
16.2 MARKET SIZE ESTIMATION
16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
16.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
16.2.4 TOP-DOWN APPROACH
16.2.5 BASE NUMBER CALCULATION
16.2.5.1 Company presentations
16.2.5.2 Primary interviews
16.2.6 VOLUME ESTIMATION
16.2.7 DEMAND-SIDE APPROACH
16.3 MARKET BREAKDOWN AND DATA TRIANGULATION
16.4 MARKET SHARE ASSESSMENT
16.5 RESEARCH ASSUMPTIONS
16.5.1 STUDY ASSUMPTIONS
16.5.2 GROWTH RATE ASSUMPTIONS
16.6 RISK ASSESSMENT
16.6.1 RESEARCH LIMITATIONS
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 ANIMAL GENETICS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES
TABLE 3 MILK PRODUCTION: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES
TABLE 4 PER CAPITA CONSUMPTION OF MEAT: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES
TABLE 5 WHITE SPACE OPPORTUNITIES IN ANIMAL GENETICS MARKET
TABLE 6 INTERCONNECTED MARKETS IN ANIMAL GENETICS MARKET
TABLE 7 CROSS SECTOR MARKETS IN ANIMAL GENETICS MARKET
TABLE 8 STRATEGIC MOVES BY TIER-1,2,3 PLAYERS IN ANIMAL GENETICS MARKET
TABLE 9 ANIMAL GENETICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 10 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 11 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, BY PRODUCT AND SERVICE MARKET (2023–2025) (USD)
TABLE 12 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY, 2023?2025 (USD)
TABLE 13 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER, 2023?2025 (USD)
TABLE 14 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023?2025 (USD)
TABLE 15 IMPORT DATA FOR HS CODE 050110, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 16 EXPORT DATA FOR HS CODE 051110, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 17 ANIMAL GENETICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027
TABLE 18 ACCELERATING DAIRY CATTLE GENETIC IMPROVEMENT THROUGH GENOMIC TESTING
TABLE 19 IMPROVING SWINE PRODUCTIVITY THROUGH ADVANCED GENOMIC BREEDING
TABLE 20 ADVANCING POULTRY BREEDING THROUGH GENOMIC SELECTION AND PHENOTYPING
TABLE 21 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 22 ASIA PACIFIC: IMPACT DUE TO THE US TARIFFS
TABLE 23 EUROPE: IMPACT DUE TO THE US TARIFFS
TABLE 24 ANIMAL GENETICS MARKET: MAJOR PATENTS
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN ANIMAL GENETICS MARKET
TABLE 26 BEST PRACTICES IN ANIMAL GENETICS MARKET
TABLE 27 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET
TABLE 28 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 29 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 30 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 31 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 32 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES
TABLE 34 KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USERS
TABLE 35 ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 36 ANIMAL GENETICS MARKET FOR LIVE ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 BOVINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 PORCINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 CANINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 POULTRY GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 OTHER LIVE ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 43 ANIMAL GENETIC PRODUCTS & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 45 ANIMAL GENETIC MATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47 ANIMAL GENETICS MARKET FOR SEMEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 CONVENTIONAL SEMEN VS. SEXED SEMEN: EVALUATION CRITERIA
TABLE 49 KEY PLAYERS OFFERING BOVINE SEMEN
TABLE 50 BOVINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 KEY PLAYERS OFFERING PORCINE SEMEN
TABLE 52 PORCINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 EQUINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 CANINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 ANIMAL GENETICS MARKET FOR OTHER ANIMAL SEMEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 57 ANIMAL GENETICS MARKET FOR EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 ANIMAL GENETICS MARKET FOR BOVINE EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 ANIMAL GENETICS MARKET FOR EQUINE EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 ANIMAL GENETICS MARKET FOR OTHER ANIMAL EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 62 ANIMAL GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 KEY GENETIC DISEASE TESTING SERVICES OFFERED, BY COMPANY
TABLE 64 GENETIC DISEASE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 KEY GENETIC TRAIT TESTING SERVICES OFFERED, BY COMPANY
TABLE 66 GENETIC TRAIT TESTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 67 GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 BOVINE GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 OTHER GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 KEY DNA TYPING SERVICES OFFERED, BY COMPANY
TABLE 71 ANIMAL DNA TYPING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 OTHER ANIMAL GENETICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 74 ANIMAL GENETIC TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 ANIMAL GENETICS MARKET FOR NGS (NEXT GENERATION SEQUENCING), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 ANIMAL GENETICS MARKET FOR PCR (POLYMERASE CHAIN REACTION), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 ANIMAL GENETICS MARKET FOR RDNA (RECOMBINANT DNA TECHNOLOGY), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 ANIMAL GENETICS MARKET FOR MICROARRAY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 ANIMAL GENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 81 ANIMAL GENETICS MARKET, BY END USER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 ANIMAL GENETICS MARKET FOR ANIMAL FARMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 ANIMAL GENETICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 ANIMAL GENETICS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85 ANIMAL GENETICS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 ANIMAL GENETICS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 87 NORTH AMERICA: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 NORTH AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 89 NORTH AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 90 NORTH AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91 NORTH AMERICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 92 NORTH AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 93 NORTH AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 NORTH AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 NORTH AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 96 NORTH AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 97 NORTH AMERICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 98 US: MACROECONOMIC INDICATORS
TABLE 99 US: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 100 US: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 101 US: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 US: ANIMAL GENETIC MATERIALS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103 US: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 US: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 US: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 106 US: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 107 US: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 108 CANADA: MACROECONOMIC INDICATORS
TABLE 109 CANADA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 110 CANADA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 111 CANADA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 112 CANADA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113 CANADA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114 CANADA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 CANADA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 116 CANADA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 117 CANADA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 118 EUROPE: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 120 EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 121 EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 EUROPE: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 123 EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124 EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125 EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 127 EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 128 EUROPE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 129 GERMANY: MACROECONOMIC INDICATORS
TABLE 130 GERMANY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 131 GERMANY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 132 GERMANY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 GERMANY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134 GERMANY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135 GERMANY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 GERMANY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 137 GERMANY: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 138 GERMANY: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 139 UK: MACROECONOMIC INDICATORS
TABLE 140 UK: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 141 UK: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 142 UK: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143 UK: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144 UK: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145 UK: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 UK: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 147 UK: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 148 UK: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 149 FRANCE: MACROECONOMIC INDICATORS
TABLE 150 FRANCE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 151 FRANCE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 152 FRANCE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153 FRANCE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154 FRANCE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155 FRANCE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 157 FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 158 FRANCE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 159 FRANCE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 160 ITALY: MACROECONOMIC INDICATORS
TABLE 161 ITALY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 162 ITALY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 163 ITALY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164 ITALY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165 ITALY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 ITALY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 ITALY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 168 ITALY: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 169 ITALY: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 170 SPAIN: MACROECONOMIC INDICATORS
TABLE 171 SPAIN: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 172 SPAIN: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 173 SPAIN: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174 SPAIN: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175 SPAIN: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176 SPAIN: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 SPAIN: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 178 SPAIN: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 179 SPAIN: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 180 NETHERLANDS: MACROECONOMIC INDICATORS
TABLE 181 NETHERLANDS: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 182 NETHERLANDS: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 183 NETHERLANDS: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184 NETHERLANDS: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185 NETHERLANDS: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 NETHERLANDS: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 NETHERLANDS: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 188 NETHERLANDS: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 189 NETHERLANDS: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 190 REST OF EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 191 REST OF EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 192 REST OF EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 REST OF EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 REST OF EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 REST OF EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 REST OF EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 197 REST OF EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 198 REST OF EUROPE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 199 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 201 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 202 ASIA PACIFIC: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203 ASIA PACIFIC: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 204 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 ASIA PACIFIC: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 ASIA PACIFIC: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 ASIA PACIFIC: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 ASIA PACIFIC: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 209 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 210 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 1 ANIMAL GENETICS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES
TABLE 3 MILK PRODUCTION: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES
TABLE 4 PER CAPITA CONSUMPTION OF MEAT: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES
TABLE 5 WHITE SPACE OPPORTUNITIES IN ANIMAL GENETICS MARKET
TABLE 6 INTERCONNECTED MARKETS IN ANIMAL GENETICS MARKET
TABLE 7 CROSS SECTOR MARKETS IN ANIMAL GENETICS MARKET
TABLE 8 STRATEGIC MOVES BY TIER-1,2,3 PLAYERS IN ANIMAL GENETICS MARKET
TABLE 9 ANIMAL GENETICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 10 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 11 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, BY PRODUCT AND SERVICE MARKET (2023–2025) (USD)
TABLE 12 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY, 2023?2025 (USD)
TABLE 13 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER, 2023?2025 (USD)
TABLE 14 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023?2025 (USD)
TABLE 15 IMPORT DATA FOR HS CODE 050110, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 16 EXPORT DATA FOR HS CODE 051110, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 17 ANIMAL GENETICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027
TABLE 18 ACCELERATING DAIRY CATTLE GENETIC IMPROVEMENT THROUGH GENOMIC TESTING
TABLE 19 IMPROVING SWINE PRODUCTIVITY THROUGH ADVANCED GENOMIC BREEDING
TABLE 20 ADVANCING POULTRY BREEDING THROUGH GENOMIC SELECTION AND PHENOTYPING
TABLE 21 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 22 ASIA PACIFIC: IMPACT DUE TO THE US TARIFFS
TABLE 23 EUROPE: IMPACT DUE TO THE US TARIFFS
TABLE 24 ANIMAL GENETICS MARKET: MAJOR PATENTS
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN ANIMAL GENETICS MARKET
TABLE 26 BEST PRACTICES IN ANIMAL GENETICS MARKET
TABLE 27 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET
TABLE 28 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 29 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 30 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 31 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 32 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES
TABLE 34 KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USERS
TABLE 35 ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 36 ANIMAL GENETICS MARKET FOR LIVE ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 BOVINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 PORCINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 CANINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 POULTRY GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 OTHER LIVE ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 43 ANIMAL GENETIC PRODUCTS & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 45 ANIMAL GENETIC MATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47 ANIMAL GENETICS MARKET FOR SEMEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 CONVENTIONAL SEMEN VS. SEXED SEMEN: EVALUATION CRITERIA
TABLE 49 KEY PLAYERS OFFERING BOVINE SEMEN
TABLE 50 BOVINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 KEY PLAYERS OFFERING PORCINE SEMEN
TABLE 52 PORCINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 EQUINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 CANINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 ANIMAL GENETICS MARKET FOR OTHER ANIMAL SEMEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 57 ANIMAL GENETICS MARKET FOR EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 ANIMAL GENETICS MARKET FOR BOVINE EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 ANIMAL GENETICS MARKET FOR EQUINE EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 ANIMAL GENETICS MARKET FOR OTHER ANIMAL EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 62 ANIMAL GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 KEY GENETIC DISEASE TESTING SERVICES OFFERED, BY COMPANY
TABLE 64 GENETIC DISEASE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 KEY GENETIC TRAIT TESTING SERVICES OFFERED, BY COMPANY
TABLE 66 GENETIC TRAIT TESTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 67 GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 BOVINE GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 OTHER GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 KEY DNA TYPING SERVICES OFFERED, BY COMPANY
TABLE 71 ANIMAL DNA TYPING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 OTHER ANIMAL GENETICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 74 ANIMAL GENETIC TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 ANIMAL GENETICS MARKET FOR NGS (NEXT GENERATION SEQUENCING), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 ANIMAL GENETICS MARKET FOR PCR (POLYMERASE CHAIN REACTION), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 ANIMAL GENETICS MARKET FOR RDNA (RECOMBINANT DNA TECHNOLOGY), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 ANIMAL GENETICS MARKET FOR MICROARRAY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 ANIMAL GENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 81 ANIMAL GENETICS MARKET, BY END USER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 ANIMAL GENETICS MARKET FOR ANIMAL FARMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 ANIMAL GENETICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 ANIMAL GENETICS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85 ANIMAL GENETICS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 ANIMAL GENETICS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 87 NORTH AMERICA: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 NORTH AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 89 NORTH AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 90 NORTH AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91 NORTH AMERICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 92 NORTH AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 93 NORTH AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 NORTH AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 NORTH AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 96 NORTH AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 97 NORTH AMERICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 98 US: MACROECONOMIC INDICATORS
TABLE 99 US: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 100 US: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 101 US: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 US: ANIMAL GENETIC MATERIALS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103 US: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 US: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 US: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 106 US: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 107 US: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 108 CANADA: MACROECONOMIC INDICATORS
TABLE 109 CANADA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 110 CANADA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 111 CANADA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 112 CANADA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113 CANADA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114 CANADA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 CANADA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 116 CANADA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 117 CANADA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 118 EUROPE: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 120 EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 121 EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 EUROPE: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 123 EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124 EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125 EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 127 EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 128 EUROPE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 129 GERMANY: MACROECONOMIC INDICATORS
TABLE 130 GERMANY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 131 GERMANY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 132 GERMANY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 GERMANY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134 GERMANY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135 GERMANY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 GERMANY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 137 GERMANY: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 138 GERMANY: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 139 UK: MACROECONOMIC INDICATORS
TABLE 140 UK: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 141 UK: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 142 UK: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143 UK: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144 UK: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145 UK: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 UK: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 147 UK: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 148 UK: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 149 FRANCE: MACROECONOMIC INDICATORS
TABLE 150 FRANCE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 151 FRANCE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 152 FRANCE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153 FRANCE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154 FRANCE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155 FRANCE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 157 FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 158 FRANCE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 159 FRANCE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 160 ITALY: MACROECONOMIC INDICATORS
TABLE 161 ITALY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 162 ITALY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 163 ITALY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164 ITALY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165 ITALY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 ITALY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 ITALY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 168 ITALY: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 169 ITALY: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 170 SPAIN: MACROECONOMIC INDICATORS
TABLE 171 SPAIN: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 172 SPAIN: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 173 SPAIN: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174 SPAIN: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175 SPAIN: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176 SPAIN: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 SPAIN: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 178 SPAIN: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 179 SPAIN: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 180 NETHERLANDS: MACROECONOMIC INDICATORS
TABLE 181 NETHERLANDS: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 182 NETHERLANDS: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 183 NETHERLANDS: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184 NETHERLANDS: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185 NETHERLANDS: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 NETHERLANDS: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 NETHERLANDS: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 188 NETHERLANDS: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 189 NETHERLANDS: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 190 REST OF EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 191 REST OF EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 192 REST OF EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 REST OF EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 REST OF EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 REST OF EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 REST OF EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 197 REST OF EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 198 REST OF EUROPE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 199 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 201 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 202 ASIA PACIFIC: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203 ASIA PACIFIC: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 204 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 ASIA PACIFIC: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 ASIA PACIFIC: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 ASIA PACIFIC: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 ASIA PACIFIC: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 209 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 210 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 ANIMAL GENETICS MARKET: SEGMENTS CONSIDERED
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL ANIMAL GENETICS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL GENETICS MARKET, 2024–2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ANIMAL GENETICS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN ANIMAL GENETICS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ANIMAL GENETICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8 GROWING ADOPTION OF GENETIC TESTING TO DRIVE MARKET GROWTH
FIGURE 9 ANIMAL FARMS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2025
FIGURE 10 INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 11 ANIMAL GENETICS MARKET: MARKET DYNAMICS
FIGURE 12 ANIMAL GENETICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 13 SUPPLY CHAIN ANALYSIS
FIGURE 14 ANIMAL GENETICS PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS
FIGURE 15 ANIMAL GENETICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 17 INVESTMENT & FUNDING SCENARIO, 2023–2026
FIGURE 18 ANIMAL GENETICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS, JANUARY 2016–MAY 2026
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR ANIMAL GENETIC PRODUCTS& SERVICES PATENTS, JANUARY 2016–JUNE 2026
FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN ANIMAL GENETICS MARKET
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES
FIGURE 22 KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USER
FIGURE 23 NORTH AMERICA: ANIMAL GENETICS MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: ANIMAL GENETICS MARKET SNAPSHOT
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN ANIMAL GENETICS MARKET, 2023–2025 (USD MILLION)
FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 27 US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025
FIGURE 28 EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025
FIGURE 29 ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30 ANIMAL GENETICS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 31 ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32 EV/EBITDA OF KEY VENDORS FOR ANIMAL GENETICS, 2025
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR ANIMAL GENETICS, 2025
FIGURE 34 ANIMAL GENETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 35 GENUS PLC: COMPANY SNAPSHOT (2025)
FIGURE 36 NEOGEN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 39 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025)
FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
FIGURE 41 ANIMAL GENETICS MARKET: RESEARCH DESIGN
FIGURE 42 KEY DATA FROM SECONDARY SOURCES
FIGURE 43 PRIMARY SOURCES
FIGURE 44 KEY DATA FROM PRIMARY SOURCES
FIGURE 45 KEY INDUSTRY INSIGHTS
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: GENUS PLC (2025)
FIGURE 52 BOTTOM-UP APPROACH
FIGURE 53 TOP-DOWN APPROACH
FIGURE 54 SUPPLY-SIDE ANALYSIS: ANIMAL GENETICS MARKET (2025)
FIGURE 55 DEMAND-SIDE APPROACH
FIGURE 56 ANIMAL GENETICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031)
FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 1 ANIMAL GENETICS MARKET: SEGMENTS CONSIDERED
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL ANIMAL GENETICS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL GENETICS MARKET, 2024–2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ANIMAL GENETICS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN ANIMAL GENETICS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ANIMAL GENETICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8 GROWING ADOPTION OF GENETIC TESTING TO DRIVE MARKET GROWTH
FIGURE 9 ANIMAL FARMS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2025
FIGURE 10 INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 11 ANIMAL GENETICS MARKET: MARKET DYNAMICS
FIGURE 12 ANIMAL GENETICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 13 SUPPLY CHAIN ANALYSIS
FIGURE 14 ANIMAL GENETICS PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS
FIGURE 15 ANIMAL GENETICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 17 INVESTMENT & FUNDING SCENARIO, 2023–2026
FIGURE 18 ANIMAL GENETICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS, JANUARY 2016–MAY 2026
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR ANIMAL GENETIC PRODUCTS& SERVICES PATENTS, JANUARY 2016–JUNE 2026
FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN ANIMAL GENETICS MARKET
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES
FIGURE 22 KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USER
FIGURE 23 NORTH AMERICA: ANIMAL GENETICS MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: ANIMAL GENETICS MARKET SNAPSHOT
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN ANIMAL GENETICS MARKET, 2023–2025 (USD MILLION)
FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 27 US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025
FIGURE 28 EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025
FIGURE 29 ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30 ANIMAL GENETICS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 31 ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32 EV/EBITDA OF KEY VENDORS FOR ANIMAL GENETICS, 2025
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR ANIMAL GENETICS, 2025
FIGURE 34 ANIMAL GENETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 35 GENUS PLC: COMPANY SNAPSHOT (2025)
FIGURE 36 NEOGEN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 39 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025)
FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
FIGURE 41 ANIMAL GENETICS MARKET: RESEARCH DESIGN
FIGURE 42 KEY DATA FROM SECONDARY SOURCES
FIGURE 43 PRIMARY SOURCES
FIGURE 44 KEY DATA FROM PRIMARY SOURCES
FIGURE 45 KEY INDUSTRY INSIGHTS
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: GENUS PLC (2025)
FIGURE 52 BOTTOM-UP APPROACH
FIGURE 53 TOP-DOWN APPROACH
FIGURE 54 SUPPLY-SIDE ANALYSIS: ANIMAL GENETICS MARKET (2025)
FIGURE 55 DEMAND-SIDE APPROACH
FIGURE 56 ANIMAL GENETICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031)
FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY
